The medical community is outraged by a 5,500 % price hike for Daraprim, after a big NY-based pharmaceutical company purchased the patent for it. The drug has been on the market for over 60 years, and can be essential to certain AIDS and cancer treatments. The New York-based Turing Pharmaceuticals raised the price of Daraprim from $13.50 to $750 per pill in just over a month after buying the rights for the drug from Impax Laboratories.
This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
0 comments:
Post a Comment